Vaxcyte

-$0.23 (-0.91%) As of 1:57 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxcyte and other ETFs, options, and stocks.

About PCVX

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.

CEO
Grant E. Pickering
Employees
89
Headquarters
San Carlos, California
Founded
2013

PCVX Key Statistics

Market cap
1.46B
Price-Earnings ratio
—
Dividend yield
—
Average volume
337.40K
High today
$25.48
Low today
$24.52
Open price
$24.52
Volume
24.26K
52 Week high
$27.44
52 Week low
$16.78

PCVX Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.63 per share
Actual
-$0.68 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure